PE20001414A1 - Procedimiento de preparacion de globulos que contienen 50% en peso o mas de una sustancia farmaceutica de hidrosolubilidad - Google Patents

Procedimiento de preparacion de globulos que contienen 50% en peso o mas de una sustancia farmaceutica de hidrosolubilidad

Info

Publication number
PE20001414A1
PE20001414A1 PE2000000005A PE0000052000A PE20001414A1 PE 20001414 A1 PE20001414 A1 PE 20001414A1 PE 2000000005 A PE2000000005 A PE 2000000005A PE 0000052000 A PE0000052000 A PE 0000052000A PE 20001414 A1 PE20001414 A1 PE 20001414A1
Authority
PE
Peru
Prior art keywords
weight
procedure
average
water solubility
pharmaceutical substance
Prior art date
Application number
PE2000000005A
Other languages
English (en)
Inventor
Iris Ziegler
Johannes Heinrich Bartholomaus
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of PE20001414A1 publication Critical patent/PE20001414A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION DE GLOBULOS CARACTERIZADO POR UN CONTENIDO a)MAYOR DE 5O% EN PESO DE UNA SUSTANCIA ACTIVA TAL COMO CLORHIDRATO DE TRAMADOL, METAMIZOL SODICO, CLORHIDRATO DE DIFENHIDRAMINA CON UNA HIDROSOLUBILIDAD > 0.5 g/ml; b)COMO MAXIMO 50% EN PESO DE UNA COMBINACION DE i)UNA CELULOSA MICROCRISTALINA CON UNA GRANULOMETRIA PROMEDIO DE 15µm A 20µm, ii)HIDROXIPROPILCELULOSA DE BAJA SUSTITUCION CON UNA GRANULOMETRIA PROMEDIO DE 10µm A 25µm SIENDO LA RELACION PONDERAL DE SUSTANCIA ACTIVA A CELULOSA DE 4:6 HASTA 6:4; c)POR INCORPORARSE A LA MEZCLA UNA CANTIDAD DE AGUA INDISPENSABLE PARA OBTENER UNA PLASTICIDAD SUFICIENTE PARA LA EXTRUSION Y ESFERONIZACION. LOS GLOBULOS ESTAN PROVISTOS DE UN REVESTIMIENTO DE LIBERACION RETARDADA O UN REVESTIMIENTO RESISTENTE AL JUGO GASTRICO Y SON ENVASADOS EN CAPSULAS O COMPRIMIDOS EN FORMA DE TABLETAS
PE2000000005A 1999-01-18 2000-01-04 Procedimiento de preparacion de globulos que contienen 50% en peso o mas de una sustancia farmaceutica de hidrosolubilidad PE20001414A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19901692A DE19901692C2 (de) 1999-01-18 1999-01-18 Verfahren zur Herstellung von Pellets mit einem Gehalt von bis zu 90 Gew.% eines pharmazeutischen Wirkstoffes

Publications (1)

Publication Number Publication Date
PE20001414A1 true PE20001414A1 (es) 2000-12-23

Family

ID=7894569

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000000005A PE20001414A1 (es) 1999-01-18 2000-01-04 Procedimiento de preparacion de globulos que contienen 50% en peso o mas de una sustancia farmaceutica de hidrosolubilidad

Country Status (18)

Country Link
US (1) US6558704B1 (es)
EP (1) EP1020181A1 (es)
JP (1) JP2000212068A (es)
KR (1) KR20000076475A (es)
CN (1) CN1161108C (es)
AU (1) AU764280C (es)
CA (1) CA2295470A1 (es)
CO (1) CO4910118A1 (es)
CZ (1) CZ291936B6 (es)
DE (1) DE19901692C2 (es)
HU (1) HUP0000141A3 (es)
IL (1) IL134079A (es)
NZ (1) NZ502264A (es)
PE (1) PE20001414A1 (es)
PL (1) PL337864A1 (es)
RU (1) RU2221553C2 (es)
SK (1) SK285423B6 (es)
ZA (1) ZA200000169B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE279186T1 (de) * 1999-08-31 2004-10-15 Gruenenthal Gmbh Retardierte darreichungsform enthaltend tramadolsaccharinat
FR2827771B1 (fr) * 2001-07-25 2003-10-24 Apis Spheromont Formulation et procede de preparation de spheroides pouvant etre fortement titres et a dispersion rapide
US20050182056A9 (en) * 2002-02-21 2005-08-18 Seth Pawan Modified release formulations of at least one form of tramadol
US8128957B1 (en) 2002-02-21 2012-03-06 Valeant International (Barbados) Srl Modified release compositions of at least one form of tramadol
BR0312206A (pt) * 2002-06-27 2005-04-12 Cilag Ag Formulações de pélete esférico
TW200404004A (en) * 2002-09-09 2004-03-16 Ss Pharmaceutical Co Molded medicament for promotion of sleeping
KR100510270B1 (ko) * 2002-11-29 2005-08-26 센츄론(주) 펠렛타이저를 이용한 서방성 제제의 제조방법
US9107804B2 (en) 2002-12-10 2015-08-18 Nortec Development Associates, Inc. Method of preparing biologically active formulations
WO2004112756A1 (en) * 2003-06-26 2004-12-29 Isa Odidi Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US20060024361A1 (en) * 2004-07-28 2006-02-02 Isa Odidi Disintegrant assisted controlled release technology
US10624858B2 (en) * 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
EP1629834A1 (en) † 2004-08-27 2006-03-01 KRKA, D.D., Novo Mesto Sustained release pharmaceutical composition of tolterodine
US8221792B2 (en) * 2005-07-07 2012-07-17 Farnam Companies, Inc. Sustained release pharmaceutical compositions for highly water soluble drugs
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US20070190141A1 (en) * 2006-02-16 2007-08-16 Aaron Dely Extended release opiate composition
US9561188B2 (en) 2006-04-03 2017-02-07 Intellipharmaceutics Corporation Controlled release delivery device comprising an organosol coat
US20190083399A9 (en) * 2006-04-03 2019-03-21 Isa Odidi Drug delivery composition
US10960077B2 (en) * 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
US7979151B2 (en) * 2007-12-06 2011-07-12 International Business Machines Corporation Run-time dispatch system for enhanced product characterization capability
TWI400089B (zh) * 2009-11-24 2013-07-01 Nippon Soda Co 羥烷基纖維素微粒子
DE102012007671A1 (de) 2012-04-16 2013-10-17 Acino Pharma Ag Pellets mit hohem Wirkstoffgehalt
EP3892263A1 (en) 2016-03-25 2021-10-13 Universiteit Gent Oral dosage form
US10966928B2 (en) 2016-03-25 2021-04-06 Universiteit Gent Oral dosage form
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
WO2018087109A1 (de) 2016-11-08 2018-05-17 Grünenthal GmbH Multipartikuläre arzneiform mit kontrollierter freisetzung von metamizol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234697A (en) * 1992-06-22 1993-08-10 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing salts of bile acids
DE4329794C2 (de) * 1993-09-03 1997-09-18 Gruenenthal Gmbh Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
DE19710008A1 (de) * 1997-03-12 1998-09-17 Basf Ag Feste, mindestens zweiphasige Zubereitungsformen eines Opioid-Analgeticums mit verzögerter Freisetzung

Also Published As

Publication number Publication date
CO4910118A1 (es) 2000-04-24
SK285423B6 (sk) 2007-01-04
DE19901692C2 (de) 2002-06-20
ZA200000169B (en) 2000-08-07
HUP0000141A3 (en) 2001-01-29
IL134079A0 (en) 2001-04-30
IL134079A (en) 2004-12-15
CN1270025A (zh) 2000-10-18
CA2295470A1 (en) 2000-07-18
AU1244200A (en) 2000-07-20
AU764280B2 (en) 2003-08-14
AU764280C (en) 2004-06-24
CZ2000167A3 (cs) 2000-09-13
HU0000141D0 (en) 2000-03-28
KR20000076475A (ko) 2000-12-26
SK682000A3 (en) 2000-08-14
DE19901692A1 (de) 2000-07-20
US6558704B1 (en) 2003-05-06
RU2221553C2 (ru) 2004-01-20
PL337864A1 (en) 2000-07-31
CN1161108C (zh) 2004-08-11
JP2000212068A (ja) 2000-08-02
EP1020181A1 (de) 2000-07-19
HUP0000141A2 (hu) 2000-12-28
NZ502264A (en) 2001-11-30
CZ291936B6 (cs) 2003-06-18

Similar Documents

Publication Publication Date Title
PE20001414A1 (es) Procedimiento de preparacion de globulos que contienen 50% en peso o mas de una sustancia farmaceutica de hidrosolubilidad
ES2231873T3 (es) Procedimiento de preparacion de formas solidas de valsartan para dosificacion oral.
FI117042B (fi) Oraalisesti annettavat farmaseuttiset formulaatiot
WO2004012700A3 (en) Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release
BRPI0015567B8 (pt) composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica
ES2331046T1 (es) Formulacion de liberacion controlada.
PE71699A1 (es) Composicion farmaceutica de descarboetoxiloratadina sin lactosa, no higroscopica y anhidra
IL161587A (en) Pharmaceutical composition containing 3 - (3 - dimethylamino - 1 - ethyl - 2 - methyl - propyl) phenol and providing delayed release of the active ingredient
AR066313A2 (es) Una formulacion de liberacion controlada de galantamina, una forma farmaceutica de dosificacion, un proceso para la preparacion de dicha formulacion, y el uso de dicha formulacion para la manufactura de un medicamento
CO5160287A1 (es) Formulacion de liberacion controlada de divalproex sodico
AR028504A2 (es) Combinacion, metodo para mejorar la apariencia corporal de un mamifero, composicion farmaceutica, uso de dicha combinacion para la preparacion de un medicamento para la prevencion, demora de progreso, o tratamiento de desordenes metabolicos, y paquete comercial
ATE307569T1 (de) Gelierbare pharmazeutische zusammensetzungen
CA2354057A1 (en) Sustained release tablet containing hydrocolloid and cellulose ether
IL174830A0 (en) Pellets containing venlafaxine hydrochloride, pharmaceutical compositions comprising them and processes for their preparation
HK1056326A1 (en) Process for preparing pharmaceutical compositions for use with soft gelatin formulations
FI117373B (fi) Parasetamolia ja domperidonia sisältävä kalvopäällysteinen tabletti
ITRM20000667A1 (it) Compressa matrice che permette la liberazione prolungata di trimetazidina dopo somministrazione per via orale.
AR019899A1 (es) Composicion farmaceutica y un procedimiento para prepararla.
HU211478A9 (en) Pharmaceutical composition and process for the preparation thereof
RU2006137329A (ru) Распадающиеся таблетки, содержащие ликарбазепин
NO303669B1 (no) FremgangsmÕte for fremstilling av en tablett eller dragÚpreparat
GR1004193B (el) Φαρμακευτικη συνθεση περιεχουσα σιταλοπραμη
PT1305057E (pt) Composicao de biomateria microparticular para uso medicinal
UA89349C2 (uk) Таблетка без покриття, яка містить оланзапін, та спосіб її одержання
AR025879A1 (es) Granulaciones de celulosa hidrolizada de sales de farmacos

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed